優品360(02360.HK)變更所得款項用途
優品360(02360.HK)公布,就2018年12月底上市一事,未動用的所得款項淨額約1.05億元。經審慎周詳考慮現時營商環境及集團的發展需要後,董事會已決議將部分未動用所得款項淨額中6,000萬元的用途,變更為用作支付收購持有物業的目標公司的部分代價。
該物業為觀塘偉業街108號絲寶國際大廈11樓1、2、3、5、6、7、8、9、10、11、12、15及16號辦公室以及3樓P59、P60及P65號停車位的商業物業。該物業將會被集團用作於香港的穩定的總辦公室,以作為香港業務及發展境外零售業務的行政及管理總部。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.